Norris Medicines Ltd. shows no change in shareholding across Promoters, Institutions, and Public, indicating a lack of interest or confidence among shareholders.

In contrast, the sector averages also reflect no change, suggesting that the overall sentiment in the Pharma sector is stagnant or bearish.

Top movers in the sector highlight divergence, with SUDARSHAN seeing significant institutional buying, while Norris remains flat, indicating it is not aligning with sector trends.